The 9 analysts offering 1 year price forecasts for NCH2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 11 analysts giving stock ratings to NCH2 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NCH2 EPS for the last quarter is 0.05 EUR despite the estimation of 0.01 EUR. In the next quarter EPS is expected to reach −0.04 EUR. Track more of THYSSENKRUPP NUCERA financials and stay on top of what is up with the company.
In the next quarter THYSSENKRUPP NUCERA revenue is expected to reach 248.60 M EUR. Check out THYSSENKRUPP NUCERA revenue and earnings and make informed decisions.
According to analysts, NCH2 price target is 13.94 EUR with a max estimate of 20.00 EUR and a min estimate of 8.50 EUR. Check if this forecast comes true in a year, meanwhile watch THYSSENKRUPP NUCERA stock price chart and keep track of the current situation with NCH2 news and stock market news.
We've gathered opinions of 11 analysts rating NCH2 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.